Microparticle-delivered Cxcl9 delays the relapse of Braf inhibitor-treated melanoma

Gabriele Romano; Francesca Paradiso; John P Miller; Roger J Liang; Jennifer A Wargo; Francesca Taraballi; James C Costello; Lawrence N Kwong

doi:10.1101/2022.05.24.493271

New Results

Microparticle-delivered Cxcl9 delays the relapse of Braf inhibitor-treated melanoma

Gabriele Romano, Francesca Paradiso, John P Miller, Roger J Liang, Jennifer A Wargo, Francesca Taraballi, James C Costello, Lawrence N Kwong

doi: https://doi.org/10.1101/2022.05.24.493271

Gabriele Romano

1Department of Pharmacology and Physiology, Drexel University College of Medicine, Philadelphia, Pennsylvania

2Department of Translational Molecular Pathology, University of Texas MD Anderson Cancer Center, Houston, Texas

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
For correspondence: gr476@drexel.edu LKwong@mdanderson.org

Francesca Paradiso

3Center for Musculoskeletal Regeneration, Department of Orthopedics & Sports Medicine, Houston Methodist Research Institute, Houston, Texas

4Reproductive Biology and Gynaecological Oncology Group, Swansea University Medical School, Swansea, United Kingdom

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

John P Miller

5Department of Genomic Medicine, University of Texas MD Anderson Cancer Center, Houston, Texas

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Roger J Liang

2Department of Translational Molecular Pathology, University of Texas MD Anderson Cancer Center, Houston, Texas

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Jennifer A Wargo

6Department of Surgical Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Francesca Taraballi

3Center for Musculoskeletal Regeneration, Department of Orthopedics & Sports Medicine, Houston Methodist Research Institute, Houston, Texas

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

James C Costello

7Department of Pharmacology, University of Colorado Anschutz Medical Campus, Aurora, Colorado

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Lawrence N Kwong

2Department of Translational Molecular Pathology, University of Texas MD Anderson Cancer Center, Houston, Texas

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
For correspondence: gr476@drexel.edu LKwong@mdanderson.org

Abstract
Full Text
Info/History
Metrics
Supplementary material
Preview PDF

Supplementary Data[supplements/493271_file02.pdf]

View the discussion thread.

PreviousNext

Posted May 25, 2022.

Download PDF

Supplementary Material

Thank you for your interest in spreading the word about bioRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Your Email *

Your Name *

Send To *

Enter multiple addresses on separate lines or separate them with commas.

You are going to email the following Microparticle-delivered Cxcl9 delays the relapse of Braf inhibitor-treated melanoma

Message Subject (Your Name) has forwarded a page to you from bioRxiv

Message Body (Your Name) thought you would like to see this page from the bioRxiv website.

Your Personal Message

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Microparticle-delivered Cxcl9 delays the relapse of Braf inhibitor-treated melanoma

Gabriele Romano, Francesca Paradiso, John P Miller, Roger J Liang, Jennifer A Wargo, Francesca Taraballi, James C Costello, Lawrence N Kwong

bioRxiv 2022.05.24.493271; doi: https://doi.org/10.1101/2022.05.24.493271

Share This Article:

Citation Tools

Microparticle-delivered Cxcl9 delays the relapse of Braf inhibitor-treated melanoma

Gabriele Romano, Francesca Paradiso, John P Miller, Roger J Liang, Jennifer A Wargo, Francesca Taraballi, James C Costello, Lawrence N Kwong

bioRxiv 2022.05.24.493271; doi: https://doi.org/10.1101/2022.05.24.493271

Citation Manager Formats

BibTeX
Bookends
EasyBib
EndNote (tagged)
EndNote 8 (xml)
Medlars
Mendeley
Papers
RefWorks Tagged
Ref Manager
RIS
Zotero

Tweet Widget
Facebook Like
Google Plus One

Subject Area

Cancer Biology

Subject Areas

All Articles

Animal Behavior and Cognition (4382)
Biochemistry (9591)
Bioengineering (7090)
Bioinformatics (24858)
Biophysics (12611)
Cancer Biology (9956)
Cell Biology (14354)
Clinical Trials (138)
Developmental Biology (7948)
Ecology (12105)
Epidemiology (2067)
Evolutionary Biology (15988)
Genetics (10925)
Genomics (14738)
Immunology (9869)
Microbiology (23661)
Molecular Biology (9484)
Neuroscience (50861)
Paleontology (369)
Pathology (1539)
Pharmacology and Toxicology (2682)
Physiology (4013)
Plant Biology (8657)
Scientific Communication and Education (1508)
Synthetic Biology (2394)
Systems Biology (6434)
Zoology (1346)